Ya Jin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ya jin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ya Jin Today - Breaking & Trending Today

アングル:酒造大手、コロナ後にらみ高級スピリッツ市場に照準

酒造大手各社は1本200ドル(約2万2000円)以上する高級スピリッツ(蒸留酒)の売り上げを伸ばそうと、買収や合弁などの戦略を進めている。市場規模500億ドルのこの分野は全体が1兆ドルのアルコール飲料市場の中で最も成長スピードが速い上に、コロナ禍収束後にさらなる拡大が見込まれるためだ。 ....

Ya Jin , Corona Wazawai , Moe Hennessy , Ya Hotel , Thomson Reuters , Bangalore Milan , Sun Reuters , Reuters France , Moe Hennessy Louis Vuitton , New Corona , Limited Book , Retailers Legacy , Reuters Top News , Company Focus , Hong Kong , Textiles Apparel Legacy , Apparel And Accessories Retailers Nec Trbc Level 5 , Specialty Retailers Trbc Level 3 , Top News , Food Processing Legacy , All Retail , Pat Sea , United States , Human Diseases Conditions , Wealth Management Trbc Level 5 , Company News ,

Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer


Published: May 10, 2021
 
SUZHOU and SHANGHAI, China, May 10, 2021 /PRNewswire/   Gracell Biotechnologies Inc. (NASDAQ: GRCL) ( Gracell ), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appointment of Dr. Jenny (Yajin) Ni as its Chief Technology Officer (CTO). In her role, Dr. Ni will be responsible for strategically leading CAR-T product development, Chemistry, Manufacturing, and Control (CMC), and supply chain management activities. Dr. Ni will lead the efforts to ensure the smooth technology transfer to Gracell s strategic collaborator, Lonza, for manufacturing of FasTCAR-enabled product candidates in the U.S. ....

Ya Jin , Marvin Tang , William Wei Cao , Exchange Commission , Head Of Process Development , Gracell Biotechnologies Inc , Virxsys Inc , Kyoto University , Gracell Biotechnologies , Chief Technology Officer , Process Development , Allogene Therapeutics , Tech Operations , Molecular Virology , Internal Medicine , Kunming Medical University , Private Securities Litigation Reform Act , மார்வின் டாங் , வில்லியம் வெய் சாவ் , பரிமாற்றம் தரகு , தலை ஆஃப் ப்ரோஸெஸ் வளர்ச்சி , கியோட்டோ பல்கலைக்கழகம் , தலைமை தொழில்நுட்பம் அதிகாரி , ப்ரோஸெஸ் வளர்ச்சி , தொழில்நுட்பம் செயல்பாடுகள் , மூலக்கூறு வைராலஜி ,

Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer


Share this article
Share this article
SUZHOU, China and PALO ALTO, California, May 10, 2021 /PRNewswire/   Gracell Biotechnologies Inc. (NASDAQ: GRCL) ( Gracell ), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appointment of Dr. Jenny (Yajin) Ni as its Chief Technology Officer (CTO). In her role, Dr. Ni will be responsible for strategically leading CAR-T product development, Chemistry, Manufacturing, and Control (CMC), and supply chain management activities. Dr. Ni will lead the efforts to ensure the smooth technology transfer to Gracell s strategic collaborator, Lonza, for manufacturing of FasTCAR-enabled product candidates in the U.S. ....

Ya Jin , Marvin Tang , William Wei Cao , Exchange Commission , Head Of Process Development , Gracell Biotechnologies Inc , Virxsys Inc , Kyoto University , Gracell Biotechnologies , Chief Technology Officer , Process Development , Allogene Therapeutics , Tech Operations , Molecular Virology , Internal Medicine , Kunming Medical University , Private Securities Litigation Reform Act , மார்வின் டாங் , வில்லியம் வெய் சாவ் , பரிமாற்றம் தரகு , தலை ஆஃப் ப்ரோஸெஸ் வளர்ச்சி , கியோட்டோ பல்கலைக்கழகம் , தலைமை தொழில்நுட்பம் அதிகாரி , ப்ரோஸெஸ் வளர்ச்சி , தொழில்நுட்பம் செயல்பாடுகள் , மூலக்கூறு வைராலஜி ,